Short Interest in Heart Test Laboratories, Inc. (NASDAQ:HSCS) Grows By 32.0%

Heart Test Laboratories, Inc. (NASDAQ:HSCS) was the recipient of a significant growth in short interest in the month of November. As of November 15th, there was short interest totalling 30,500 shares, a growth of 32.0% from the October 31st total of 23,100 shares. Approximately 3.7% of the shares of the stock are sold short. Based on an average trading volume of 356,800 shares, the short-interest ratio is currently 0.1 days.

Analyst Upgrades and Downgrades

Separately, Ascendiant Capital Markets restated a “buy” rating and set a $15.00 target price on shares of Heart Test Laboratories in a research report on Monday, September 23rd.

Heart Test Laboratories Trading Up 1.7 %

Shares of HSCS opened at $2.95 on Monday. The firm’s 50-day moving average is $3.38 and its two-hundred day moving average is $4.02. The firm has a market capitalization of $2.68 million, a P/E ratio of -0.14 and a beta of 3.27. The company has a current ratio of 4.49, a quick ratio of 4.02 and a debt-to-equity ratio of 0.08. Heart Test Laboratories has a twelve month low of $2.36 and a twelve month high of $25.09.

Heart Test Laboratories (NASDAQ:HSCS) last issued its quarterly earnings data on Thursday, September 12th. The company reported ($2.64) earnings per share (EPS) for the quarter. On average, research analysts predict that Heart Test Laboratories will post -9.82 earnings per share for the current fiscal year.

Heart Test Laboratories Company Profile

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.